A phase I study to evaluate AK1910 as a potential treatment for autoimmune diseases
Latest Information Update: 13 Nov 2023
At a glance
- Drugs SBI 3150 (Primary)
- Indications Autoimmune disorders
- Focus Adverse reactions
Most Recent Events
- 13 Nov 2023 New trial record